| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate |
2001-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b877e2b1b82861d4ee6c9257c6313f03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_957aad3506d1d5051aac7c2cd5d99055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_864901c84d6773c73d6393dfba8822a0 |
| publicationDate |
2003-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003065192-A1 |
| titleOfInvention |
Antimicrobial compounds and methods of use |
| abstract |
Novel antimicrobial compounds based on 5-substituted 3-isothiazolones, where the 5-substituent is an aryl or heterocyclic ether/thioether group, are disclosed. These 5-substituted 3-isothiazolones provide enhanced antimicrobial activity over that of related 3-isothiazolones, particularly when the 5-substituent is a substituted pyridinyl thioether group. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005239358-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9410045-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015259543-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010236715-A1 |
| priorityDate |
2001-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |